Loading clinical trials...
Loading clinical trials...
Betaferon Prospective Study on Adherence, Coping and Nursing Support
* The Study analyses the influence of selected factors on adherence to Betaferon treatment in patients with early multiple sclerosis (MS). The Investigator will document the relevant medical data regarding multiple sclerosis at every hospital visit, the patient will fill in two questionnaires at every visit: one about coping with the disease and the other about anxiety and depression. * The Study particularly looks at the role of the support of the patient given by the multiple sclerosis nurses.The nurse will provide additional standardised information at start of treatment and will regularly phone the patient to ask standardised questions about the general condition with regard to the treatment, the disease and social support. At the end of the Study it will be assessed if the supportive measures and the standards in terms of adherence management in the hospital have some influence to increase long-term treatment adherence.
Age
12 - No limit years
Sex
ALL
Healthy Volunteers
No
Many Locations, Argentina
Many Locations, Bahrain
Many Locations, Belgium
Many Locations, Bosnia and Herzegovina
Many Locations, Canada
Many Locations, China
Many Locations, Colombia
Many Locations, Czechia
Many Locations, Egypt
Many Locations, Estonia
Start Date
June 1, 2008
Primary Completion Date
September 1, 2013
Completion Date
October 1, 2014
Last Updated
October 16, 2015
1,723
ACTUAL participants
Interferon beta-1b (Betaseron, BAY86-5046)
DRUG
Lead Sponsor
Bayer
NCT02035514
NCT01499667
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions